Pedro Borrego

Lisbon, 1649003, Portugal

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 25 publications

Longitudinal Analysis of HIV-2 Proviral DNA Reveals Archived Protease Inhibitor Resistance and Reservoir Evolution over Eight Years.

Longitudinal Analysis of HIV-2 Proviral DNA Reveals Archived Protease Inhibitor Resistance and Reservoir Evolution over Eight Years.

Journal: International journal of molecular sciences

Published: April 15, 2026

Perceptions of the Portuguese population on vaccination - The specific view of Chronic Respiratory Disease patients.

Perceptions of the Portuguese population on vaccination - The specific view of Chronic Respiratory Disease patients.

Journal: Pulmonology

Published: November 22, 2023

An HIV-1/HIV-2 Chimeric Envelope Glycoprotein Generates Binding and Neutralising Antibodies against HIV-1 and HIV-2 Isolates.

An HIV-1/HIV-2 Chimeric Envelope Glycoprotein Generates Binding and Neutralising Antibodies against HIV-1 and HIV-2 Isolates.

Journal: International journal of molecular sciences

Published: April 03, 2023

Long-Term and Low-Level Envelope C2V3 Stimulation by Highly Diverse Virus Isolates Leads to Frequent Development of Broad and Elite Antibody Neutralization in HIV-1-Infected Individuals.

Long-Term and Low-Level Envelope C2V3 Stimulation by Highly Diverse Virus Isolates Leads to Frequent Development of Broad and Elite Antibody Neutralization in HIV-1-Infected Individuals.

Journal: Microbiology spectrum

Published: November 29, 2022

High Instantaneous Inhibitory Potential of Bictegravir and the New Spiro-β-Lactam BSS-730A for HIV-2 Isolates from RAL-Naïve and RAL-Failing Patients.

High Instantaneous Inhibitory Potential of Bictegravir and the New Spiro-β-Lactam BSS-730A for HIV-2 Isolates from RAL-Naïve and RAL-Failing Patients.

Journal: International journal of molecular sciences

Published: October 06, 2022

A Prime-Boost Immunization Strategy with Vaccinia Virus Expressing Novel gp120 Envelope Glycoprotein from a CRF02_AG Isolate Elicits Cross-Clade Tier 2 HIV-1 Neutralizing Antibodies.

A Prime-Boost Immunization Strategy with Vaccinia Virus Expressing Novel gp120 Envelope Glycoprotein from a CRF02_AG Isolate Elicits Cross-Clade Tier 2 HIV-1 Neutralizing Antibodies.

Journal: Vaccines

Published: March 02, 2020

Genotypic resistance profiles of HIV-2-infected patients from Cape Verde failing first-line antiretroviral therapy.

Genotypic resistance profiles of HIV-2-infected patients from Cape Verde failing first-line antiretroviral therapy.

Journal: AIDS (London, England)

Published: November 26, 2019

Epidemic history and baseline resistance to NS5A-specific direct acting drugs of hepatitis C virus in Spain.

Epidemic history and baseline resistance to NS5A-specific direct acting drugs of hepatitis C virus in Spain.

Journal: Scientific reports

Published: April 17, 2019

In vitro evaluation of novel reverse transcriptase inhibitors TAF (tenofovir alafenamide) and OBP-601 (2,3-didehydro-3-deoxy-4-ethynylthymidine) against multi-drug resistant primary isolates of HIV-2.

In vitro evaluation of novel reverse transcriptase inhibitors TAF (tenofovir alafenamide) and OBP-601 (2,3-didehydro-3-deoxy-4-ethynylthymidine) against multi-drug resistant primary isolates of HIV-2.

Journal: Antiviral research

Published: September 07, 2018

Epidemic history of hepatitis C virus genotypes and subtypes in Portugal.

Epidemic history of hepatitis C virus genotypes and subtypes in Portugal.

Journal: Scientific reports

Published: May 16, 2018

Correction: Evaluation of the fusion inhibitor P3 peptide as a potential microbicide to prevent HIV transmission in women.

Correction: Evaluation of the fusion inhibitor P3 peptide as a potential microbicide to prevent HIV transmission in women.

Journal: PloS one

Published: May 03, 2018

Evaluation of the fusion inhibitor P3 peptide as a potential microbicide to prevent HIV transmission in women.

Evaluation of the fusion inhibitor P3 peptide as a potential microbicide to prevent HIV transmission in women.

Journal: PloS one

Published: February 22, 2018

Showing 1-12 of 25

Last Updated: 09/26/2026